Agilent Technologies ROE 2010-2025 | A
Current and historical return on equity (ROE) values for Agilent Technologies (A) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Agilent Technologies ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-04-30 | $1.17B | $6.14B | 19.46% |
| 2025-01-31 | $1.26B | $6.03B | 20.95% |
| 2024-10-31 | $1.29B | $5.90B | 21.30% |
| 2024-07-31 | $1.41B | $5.90B | 23.40% |
| 2024-04-30 | $1.24B | $6.21B | 20.87% |
| 2024-01-31 | $1.24B | $6.19B | 21.15% |
| 2023-10-31 | $1.24B | $5.85B | 21.76% |
| 2023-07-31 | $1.13B | $5.56B | 20.37% |
| 2023-04-30 | $1.35B | $5.78B | 24.80% |
| 2023-01-31 | $1.32B | $5.61B | 25.05% |
| 2022-10-31 | $1.25B | $5.31B | 24.26% |
| 2022-07-31 | $1.33B | $5.09B | 25.59% |
| 2022-04-30 | $1.26B | $5.12B | 24.51% |
| 2022-01-31 | $1.21B | $5.15B | 23.75% |
| 2021-10-31 | $1.21B | $5.39B | 24.26% |
| 2021-07-31 | $0.99B | $4.95B | 20.38% |
| 2021-04-30 | $0.93B | $4.81B | 19.01% |
| 2021-01-31 | $0.81B | $4.80B | 16.68% |
| 2020-10-31 | $0.72B | $4.87B | 14.77% |
| 2020-07-31 | $0.69B | $4.98B | 14.29% |
| 2020-04-30 | $0.68B | $4.77B | 14.30% |
| 2020-01-31 | $0.76B | $4.85B | 15.70% |
| 2019-10-31 | $1.07B | $4.75B | 21.79% |
| 2019-07-31 | $1.07B | $4.75B | 22.01% |
| 2019-04-30 | $1.12B | $5.13B | 23.15% |
| 2019-01-31 | $1.14B | $5.04B | 24.27% |
| 2018-10-31 | $0.32B | $4.57B | 6.91% |
| 2018-07-31 | $0.30B | $4.57B | 6.43% |
| 2018-04-30 | $0.24B | $4.62B | 5.10% |
| 2018-01-31 | $0.20B | $4.53B | 4.27% |
| 2017-10-31 | $0.68B | $4.84B | 15.10% |
| 2017-07-31 | $0.63B | $4.61B | 14.44% |
| 2017-04-30 | $0.58B | $4.38B | 13.48% |
| 2017-01-31 | $0.51B | $4.30B | 11.94% |
| 2016-10-31 | $0.46B | $4.25B | 11.00% |
| 2016-07-31 | $0.48B | $4.35B | 11.38% |
| 2016-04-30 | $0.46B | $4.17B | 11.23% |
| 2016-01-31 | $0.46B | $4.05B | 11.14% |
| 2015-10-31 | $0.40B | $4.17B | 9.62% |
| 2015-07-31 | $0.28B | $4.11B | 6.22% |
| 2015-04-30 | $0.31B | $4.16B | 6.47% |
| 2015-01-31 | $0.37B | $4.24B | 7.01% |
| 2014-10-31 | $0.50B | $5.30B | 9.03% |
| 2014-07-31 | $0.69B | $5.64B | 12.58% |
| 2014-04-30 | $0.71B | $5.63B | 13.48% |
| 2014-01-31 | $0.74B | $5.45B | 14.21% |
| 2013-10-31 | $0.72B | $5.29B | 13.96% |
| 2013-07-31 | $0.94B | $4.79B | 18.18% |
| 2013-04-30 | $1.01B | $5.31B | 19.56% |
| 2013-01-31 | $1.10B | $5.35B | 21.89% |
| 2012-10-31 | $1.15B | $5.19B | 23.92% |
| 2012-07-31 | $1.02B | $4.87B | 22.09% |
| 2012-04-30 | $1.10B | $4.73B | 24.89% |
| 2012-01-31 | $1.05B | $4.50B | 24.72% |
| 2011-10-31 | $1.01B | $4.32B | 25.59% |
| 2011-07-31 | $1.02B | $4.20B | 27.55% |
| 2011-04-30 | $0.89B | $3.96B | 26.67% |
| 2011-01-31 | $0.80B | $3.34B | 26.56% |
| 2010-10-31 | $0.68B | $3.24B | 24.26% |
| 2010-07-31 | $0.42B | $2.81B | 15.80% |
| 2010-04-30 | $0.19B | $2.63B | 7.54% |
| 2010-01-31 | $-0.02B | $2.60B | -0.64% |
| 2009-10-31 | $-0.03B | $2.51B | -1.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.020B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Boston Scientific (BSX) | United States | $152.679B | 38.22 |
| Stryker (SYK) | United States | $148.653B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.422B | 0.00 |
| Medtronic (MDT) | Ireland | $115.326B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.078B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.743B | 25.54 |
| ResMed (RMD) | United States | $37.302B | 28.02 |
| GE HealthCare Technologies (GEHC) | United States | $34.401B | 16.33 |
| Terumo (TRUMY) | Japan | $24.607B | 31.96 |
| Koninklijke Philips (PHG) | Netherlands | $23.139B | 16.24 |
| Insulet (PODD) | United States | $20.361B | 79.92 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.556B | 11.92 |
| Baxter (BAX) | United States | $14.728B | 11.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.993B | 24.33 |
| Lantheus Holdings (LNTH) | United States | $5.626B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.785B | 9.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.780B | 16.89 |
| Haemonetics (HAE) | United States | $3.628B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.424B | 28.45 |
| ICU Medical (ICUI) | United States | $3.253B | 23.99 |
| QuidelOrtho (QDEL) | United States | $2.052B | 14.11 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.521B | 0.00 |
| Acuren (TIC) | United States | $1.395B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.389B | 31.24 |
| Phibro Animal Health (PAHC) | United States | $1.248B | 15.96 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Neogen (NEOG) | United States | $1.170B | 14.97 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Curaleaf Holdings (CURLF) | Canada | $0.771B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.766B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.695B | 0.00 |
| Owens & Minor (OMI) | United States | $0.627B | 5.21 |
| Evolus (EOLS) | United States | $0.611B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.584B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.38 |
| Cresco Labs (CRLBF) | United States | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Quanterix (QTRX) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.83 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.55 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| Omeros (OMER) | United States | $0.214B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.68 |
| Jushi Holdings (JUSHF) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.074B | 0.00 | |
| Zynex (ZYXI) | United States | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |